Genomic classifier (ColoPrint) predicts outcome and chemotherapy benefit in stage II and III colon cancer patients

被引：0
|
作者：
Kopetz, S. [1 ]
Jiang, Z. Q. [2 ]
Overman, M. J. [1 ]
Rosenberg, R. [3 ]
Salazar, R. [4 ]
Tabernero, J. [5 ]
Stork-Sloots, L. [6 ]
Simon, I. [7 ]
Chang, G. J. [8 ]
Maru, D. M. [9 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Kantonsspital Baden, Dept Surg, Baden, Switzerland
[4] Inst Catala Oncol IDIBELL Hospitalet de Llobregat, Dept Med Oncol, Barcelona, Spain
[5] Vail dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
[6] Agendia, Med Affairs, Amsterdam, Netherlands
[7] Agendia, Res & Dev, Amsterdam, Netherlands
[8] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2257
引用
收藏
页码：S514 / S515
页数：2
相关论文
共 50 条
  • [1] Genomic classifier (ColoPrint) to predict outcome and chemotherapy benefit in stage II and III colon cancer patients
    Kopetz, Scott
    Jiang, Zhi-Qin
    Overman, Michael J.
    Rosenberg, Robert
    Salazar, Ramon
    Tabernero, Josep
    Stork, Lisette
    Li, Ying
    Simon, Iris
    Chang, George J.
    Maru, Dipen M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Genomic classifiers (ColoPrint/MSI-Print) predict outcome and chemotherapy benefit in stage II and III colon cancer patients.
    Kopetz, Scott
    Jiang, Zhi-Qin
    Overman, Michael J.
    Dreezen, Christa
    Tian, Sun
    Li, Ying
    Simon, Iris
    Chang, George J.
    Maru, Dipen M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [3] Clinical and technical validation of a genomic classifier (ColoPrint) for predicting outcome of patients with stage II colon cancer.
    Tabernero, Josep
    Moreno, Victor
    Rosenberg, Robert
    Nitsche, Ulrich
    Bachleitner-Hofmann, Thomas
    Lanza, Giovanni
    van den Akker, Jeroen
    Roepman, Paul
    Simon, Iris
    Salazar, Ramon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [4] Validation of a genomic classifier (ColoPrint) for predicting outcome in the T3-MSS subgroup of stage II colon cancer patients
    Salazar, Ramon
    Tabernero, Josep
    Moreno, Victor
    Nitsche, Ulrich
    Bachleitner-Hofmann, Thomas
    Lanza, Giovanni
    Stork, Lisette
    Roepman, Paul
    Simon, Iris
    Rosenberg, Robert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Genomic Classifier ColoPrint Predicts Recurrence in Stage II Colorectal Cancer Patients More Accurately Than Clinical Factors
    Kopetz, Scott
    Tabernero, Josep
    Rosenberg, Robert
    Jiang, Zhi-Qin
    Moreno, Victor
    Bachleitner-Hofmann, Thomas
    Lanza, Giovanni
    Stork-Sloots, Lisette
    Maru, Dipen
    Simon, Iris
    Capella, Gabriel
    Salazar, Ramon
    [J]. ONCOLOGIST, 2015, 20 (02): : 127 - 133
  • [6] Combining clinical factors with a genomic signature (ColoPrint) for the prognosis prediction of stage II and III colon cancer patients
    Simon, I.
    Tollenaar, R.
    Mesker, W.
    Roepman, P.
    Glas, A.
    Salazar, R.
    Capella, G.
    Moreno, V.
    van't Veer, L.
    Bernards, R.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 323 - 323
  • [7] USE OF GENOMIC CLASSIFIERS (COLOPRINT) FOR PERSONALIZED TREATMENT DECISIONS IN STAGE II AND III COLON CANCER PATIENTS.
    Chang, G.
    Maru, D.
    Jiang, J.
    Overman, M.
    Stork, L.
    Li, Y.
    Simon, I.
    Kopetz, S.
    [J]. DISEASES OF THE COLON & RECTUM, 2013, 56 (04) : E245 - E245
  • [8] Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
    Chen, Xin
    Tu, Junhao
    Xu, Xiaolan
    Gu, Wen
    Qin, Lei
    Qian, Haixin
    Jia, Zhenyu
    Ma, Chuntao
    Xu, Yinkai
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer
    Maak, Matthias
    Simon, Iris
    Nitsche, Ulrich
    Roepman, Paul
    Snel, Mireille
    Glas, Annuska M.
    Schuster, Tibor
    Keller, Gisela
    Zeestraten, Eliane
    Goossens, Ines
    Janssen, Klaus-Peter
    Friess, Helmut
    Rosenberg, Robert
    [J]. ANNALS OF SURGERY, 2013, 257 (06) : 1053 - 1058
  • [10] Independent validation of a prognostic genomic profile (ColoPrint) for stage II colon cancer patients
    Rosenberg, R.
    Maak, M.
    Simon, I.
    Nitsche, U.
    Schuster, T.
    Kuenzli, B.
    Keerl, A.
    Friess, H.
    Kocher, T.
    [J]. BRITISH JOURNAL OF SURGERY, 2012, 99 : 9 - 9
12345